United Laboratories International Holdings (FRA:UNJ) Total Receivables: €542 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:UNJ United Laboratories International Holdings Ltd FRA:UNJ
85 GF Score
Price €1.00
GF Value €0.96
! 5 Warning Signs
View Full Analysis

What is United Laboratories International Holdings Total Receivables?

United Laboratories International Holdings FRA:UNJ +1.01% 85 Total Receivables is €542 Mil as of Dec. 2025. GuruFocus rates FRA:UNJ with a GF Score™ of 85/100 and a GF Value™ of €0.96. The stock has 5 warning signs investors should review.

United Laboratories International Holdings's Total Receivables for the quarter that ended in Dec. 2025 was €542 Mil.

United Laboratories International Holdings Total Receivables Related Terms

United Laboratories International Holdings Total Receivables Historical Data

* Premium members only.

The historical data trend for United Laboratories International Holdings's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

United Laboratories International Holdings Total Receivables Chart

United Laboratories International Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 513.65 649.38 792.79 791.78 542.40

United Laboratories International Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 792.79 681.73 791.78 659.54 542.40
FRA:UNJ
85GF Score
United Laboratories International Holdings Ltd FRA:UNJ
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

United Laboratories International Holdings Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of €542 Mil mean?
United Laboratories International Holdings (FRA:UNJ) has a Total Receivables of €542 Mil as of Dec. 2025. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on United Laboratories International Holdings and its competitors.
Is United Laboratories International Holdings' Total Receivables too high?
United Laboratories International Holdings' current Total Receivables is €542 Mil. Overall, United Laboratories International Holdings has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does United Laboratories International Holdings' Total Receivables compare to ZTS and UTHR?
United Laboratories International Holdings' Total Receivables of €542 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on United Laboratories International Holdings and its competitors. United Laboratories International Holdings's current Total Receivables is €542 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is United Laboratories International Holdings stock overvalued right now?
United Laboratories International Holdings (FRA:UNJ) has a current Total Receivables of €542 Mil. The stock's GF Value™ is €0.96, compared to a current price of €1.00 — trading 4.2% above its estimated fair value. The current Total Receivables is €542 Mil. United Laboratories International Holdings' overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For United Laboratories International Holdings (FRA:UNJ), the current Total Receivables is €542 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is United Laboratories International Holdings (FRA:UNJ) Overvalued in 2026?

Based on GuruFocus' analysis, United Laboratories International Holdings stock appears to be overvalued. The current stock price of €1.00 is trading 4.2% above its estimated GF Value™ of €0.96.

Key valuation signals for FRA:UNJ:

  • Total Receivables: €542 Mil
  • GF Value™: €0.96 vs. price of €1.00 (4.2% above fair value)
  • GF Score™: 85/100 with 5 warning signs

No single metric tells the full story. See the FRA:UNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

United Laboratories International Holdings Business Description

Address No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
United Laboratories International Holdings Ltd is mainly engaged in the research and development, production and sales of pharmaceuticals. The company operates in three segments: Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Finished products segment, followed by Bulk medicine. The majority of the company's sales are generated in China, followed by Europe, India and other countries.
85GF Score

Get the complete analysis for FRA:UNJ

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.00
Price
€0.96
GF Value